Little Green Pharma: Signs $2m supply agreement with Ilios Santé

Little Green Pharma Signs $2m supply agreement with Ilios Santé

  • Little Green Pharma (LGP) signs a deal with Frankfurt licenced pharmaceutical wholesaler Ilios Santé for the supply of medicinal cannabis products into Germany
  • Under the agreement, Ilios Santé must purchase minimum orders of a high-THC white-label medicinal cannabis flower product being developed by LGP
  • The contract will last for two years and will have a minimum value of $2 million
  • The company believes the agreement shows its continued success of the extensive genetics program which has resulted in “a world-class” bank of cannabis cultivars
  • Shares in Little GreenPharma close in the day in the grey, trading at 32 cents
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Experian Launches Credit Score App in ChatGPT, Enhancing Financial Access

New tool enables users to check credit scores effortlessly via ChatGPT.Highlights: Experian's app allows users to check credit...

US Senate Passes Bill Banning Issuance of CBDCs

Legislation aims to restrict the development of digital currencies by the Federal Reserve.Highlights: The US Senate approved a...

Truist Expands Open Banking Offerings with Plaid Partnership

Collaboration aims to enhance customer access to financial services.Highlights: Truist collaborates with Plaid for open banking expansion.The partnership...

UK’s National Fraud Database Reports 444,000 Fraud Cases in 2025

Cifas reveals a significant rise in reported fraud incidents across the UK.Highlights: Cifas reported 444,000 fraud cases in...